Literature DB >> 25426402

Pseudoxanthoma Elasticum Treatment with Fractional CO2 Laser.

Alessandra Grassi Salles1, Adelina Fátima do Nascimento Remigio1, Luciana Borsoi Moraes1, Andreza Cristina Camacho Varoni1, Rolf Gemperli1, Marcus Castro Ferreira1.   

Abstract

SUMMARY: Pseudoxanthoma elasticum (PE) is a rare genetic disease characterized by calcification and fragmentation of elastic fibers of the skin, retina, and cardiovascular system. We report a case of PE in which fractional carbon dioxide laser treatment was successfully used to achieve improvement of the cervical skin with 2-year follow-up, in a patient with Fitzpatrick skin type IV. After the fifth session, the patient presented with a local herpes infection. The postlaser reaction of the PE skin was similar to that of the normal skin, in terms of the duration of redness, pain, swelling, and duration of crusting. The overall cosmetic result was satisfactory, with improvement in skin texture, irregularity, volume, and distensibility. The herpetic infection reinforces the value of antiviral prophylaxis during laser treatment of extrafacial areas.

Entities:  

Year:  2014        PMID: 25426402      PMCID: PMC4229278          DOI: 10.1097/GOX.0000000000000173

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


Pseudoxanthoma elasticum (PE) is a rare autosomal recessive disease caused by mutations in ABCC6 (adenosine triphosphate-binding cassette transporter C6), located in chromosome 16.[1] Its prevalence is estimated to be 1:50,000.[2] PE involves progressive calcification and fragmentation of the elastic fibers in the skin, retina, and cardiovascular system.[3] The initial symptoms can occur at any age and are usually cutaneous: painless dyschromias or yellow-orange papules, commonly in the lateral and posterior cervical regions and in the axillary, inguinal, popliteal, and periumbilical areas.[3] The most frequent cause of morbidity is reduction of visual acuity.[4] The diagnosis is based on clinical aspects, as the lesions are very unique, and on genetic study and histological examination. Several treatments have been described for the dermatological lesions of PE: surgical excision, collagen or autologous fat injections, and even therapeutic abstention.[5,6] However, none of these treatments is completely effective or definitive. Carbon dioxide (CO2) laser skin resurfacing has been a mainstay of facial rejuvenation since its introduction in the mid-1990s.[7,8] Recently, fractional CO2 lasers were proven safe and effective not only for facial rejuvenation but also for treatments elsewhere on the body.[9-12] Because of the areas of spared epidermis and dermis, these lasers are associated with more rapid healing than fully ablative CO2 laser skin resurfacing, and downtime (recuperative period after a treatment) is proportionately reduced.[11-13] The objective of this study is to present a case of PE treated with fractional CO2 lasers.

CASE REPORT

Our patient was a 32-year-old woman, with Fitzpatrick skin type IV, who was diagnosed with PE 17 years ago. She had cutaneous involvement of the cervical, axillary, and periumbilical regions and a history of labial herpes. Her brother also had PE with cervical involvement. The patient signed an informed consent. The initial treatment was with 0.025% tretinoin cream and sunscreen. After 3 months, treatment with a fractional CO2 laser (SmartXide Dot; Deka, Florence, Italy) was applied only in the posterior cervical region (30 W; spacing 750; dwell time 500). At the second session, treatment of the anterior cervical region was included. She underwent further treatments at 2-month intervals, and the laser parameters were adjusted according to the previous treatment outcomes (Table 1). In total, she had 4 sessions for the anterior cervical region and 5 sessions for the posterior cervical region. Dipyrone 1.0 g and cold air were administered to decrease pain (Freddo; Fabinject, Taubaté, Sao Paulo, Brazil). The patient assessed pain sensations after each session on a scale from 0 to 10. The laser and clinical parameters for each session, including duration of pain, edema, hyperemia, and scabs, are shown in Table 1.
Table 1.

Laser Parameters and Clinical Progress After Each Fractional CO2 Laser Session

Laser Parameters and Clinical Progress After Each Fractional CO2 Laser Session At 15 days after the last session, she developed watery blisters or vesicles, with discharge and itching, in the cervical region (Fig. 1). The results of a biopsy were consistent with herpes simplex, and she was treated with acyclovir (1 g/d for 20 days), cephalexin, and topical betamethasone in the first 6 days. Complete resolution of the symptoms occurred after 20 days, but this area showed postinflammatory hyperpigmentation, which persisted for 18 months, when treatment with 0.015% tretinoin cream and 2% hydroquinone was prescribed with partial improvement.
Fig. 1.

Herpes simplex vesicles 15 days after the last session.

Herpes simplex vesicles 15 days after the last session. The treatment outcome was evaluated using a scar scale, which was composed of 5 parameters[14] and was filled separately by both the patient and the medical staff (average of 2 independent medical evaluators) (Tables 2 and 3). The evaluations were performed between each session and at 3, 6, 12, and 24 months after the last session.
Table 2.

Evaluation of Treatment Outcome by the Patient

Table 3.

Evaluation of Treatment Outcome by the Doctor

Evaluation of Treatment Outcome by the Patient Evaluation of Treatment Outcome by the Doctor A significant improvement in skin irregularity and elasticity was already evident 1 month after the first session. At 2 years after the last treatment, there was improvement of surface irregularities and distensibility in the cervical area. Both the patient and the medical staff were satisfied with the results (Figs. 2, 3).
Fig. 2.

Before (A) and 2 years after (B) treatment, frontal view.

Fig. 3.

Before (A) and 2 years after (B) treatment, side view.

Before (A) and 2 years after (B) treatment, frontal view. Before (A) and 2 years after (B) treatment, side view.

DISCUSSION

Lasers can be used to treat a variety of medical dermatological conditions, such as acne vulgaris, psoriasis, and vitiligo.[15,16] Fractional CO2 laser ablation improves the appearance of wrinkles, photoaging, sagging skin, acne scars, and burns, without the disadvantages and risks related to prolonged epithelialization after traditional ablative lasers, such as prolonged erythema, hypopigmentation, and even scarring. In the present case, a fractional CO2 laser was used for the treatment of cutaneous PE lesions. This treatment has not been previously used to treat this pathology.[7,9,11] We began laser treatment cautiously, using low energy, and then progressively adjusted the treatment due to the good outcomes. After the laser treatment, the reaction of the PE-affected skin was similar to that of the normal skin, in terms of erythema, pain, swelling, and duration of crusting. With increase in the dwell time, there was a tendency for longer duration of crusts. Despite the reactivation of herpes after the last session, in which the density of the treatment was increased, there was a slow but satisfactory resolution of the PE symptoms, and fortunately, the end result was not affected. This observation highlights the importance of antiviral prophylaxis in patients with a history of herpes, even when the laser treatment is extrafacial. Our patient’s clinical progress was favorable and satisfactory. The scar scale showed good sensitivity in the assessment of skin improvement. The final result after 2 years was an improvement in skin texture, surface irregularities, and distensibility.

CONCLUSIONS

We have reported the first instance of fractional CO2 laser treatment of cutaneous PE lesions. This treatment produced appropriate healing and good esthetic results.

ACKNOWLEDGMENT

We thank Rental Laser do Brasil for kindly providing the fractional CO2 laser equipment at no cost for the treatment of this patient.
  15 in total

Review 1.  Pseudoxanthoma elasticum: an update.

Authors:  D W Sherer; A N Sapadin; M G Lebwohl
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

2.  Pseudoxanthoma elasticum: Temporary treatment of chin folds and lines with injectable collagen.

Authors:  Hassan Galadari; Mark Lebwohl
Journal:  J Am Acad Dermatol       Date:  2003-11       Impact factor: 11.527

Review 3.  Lasers in dermatology: four decades of progress.

Authors:  Elizabeth L Tanzi; Jason R Lupton; Tina S Alster
Journal:  J Am Acad Dermatol       Date:  2003-07       Impact factor: 11.527

4.  Pseudoxanthoma elasticum: the end of the autosomal dominant segregation myth.

Authors:  Arthur A B Bergen
Journal:  J Invest Dermatol       Date:  2006-04       Impact factor: 8.551

5.  Laser treatment of acne, psoriasis, leukoderma, and scars.

Authors:  Divya Railan; Tina S Alster
Journal:  Semin Cutan Med Surg       Date:  2008-12

6.  Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE international research meeting.

Authors:  Jouni Uitto; Andras Váradi; Lionel Bercovitch; Patrick F Terry; Sharon F Terry
Journal:  J Invest Dermatol       Date:  2013-06       Impact factor: 8.551

7.  In vivo histological evaluation of a novel ablative fractional resurfacing device.

Authors:  Basil M Hantash; Vikramaditya P Bedi; Bhumika Kapadia; Zakia Rahman; Kerrie Jiang; Heather Tanner; Kin Foong Chan; Christopher B Zachary
Journal:  Lasers Surg Med       Date:  2007-02       Impact factor: 4.025

8.  Pulsed carbon dioxide laser resurfacing of photo-aged facial skin.

Authors:  R E Fitzpatrick; M P Goldman; N M Satur; W D Tope
Journal:  Arch Dermatol       Date:  1996-04

9.  Ablative skin resurfacing with a novel microablative CO2 laser.

Authors:  Robert H Gotkin; Deborah S Sarnoff; Giovanni Cannarozzo; Neil S Sadick; Macrene Alexiades-Armenakas
Journal:  J Drugs Dermatol       Date:  2009-02       Impact factor: 2.114

10.  An update on the ocular phenotype in patients with pseudoxanthoma elasticum.

Authors:  Martin Gliem; Julie De Zaeytijd; Robert P Finger; Frank G Holz; Bart P Leroy; Peter Charbel Issa
Journal:  Front Genet       Date:  2013-04-04       Impact factor: 4.599

View more
  3 in total

Review 1.  From variome to phenome: Pathogenesis, diagnosis and management of ectopic mineralization disorders.

Authors:  Eva Yg De Vilder; Olivier M Vanakker
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

2.  Pseudoxanthoma elasticum as a diagnostic challenge for pathologists: A rare case report.

Authors:  Namita Bhutani; Akhil Nadesan
Journal:  Ann Med Surg (Lond)       Date:  2022-04-03

Review 3.  Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives.

Authors:  Max Jonathan Stumpf; Nadjib Schahab; Georg Nickenig; Dirk Skowasch; Christian Alexander Schaefer
Journal:  Biomedicines       Date:  2021-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.